Shionogi Recalls PONSTEL Capsules Due to Failed Dissolution Specifications
Shionogi Inc. is recalling 455 bottles of PONSTEL capsules because stability testing showed low dissolution results.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which is defined as unlikely to cause adverse health consequences. The issue is a failure in dissolution specifications during stability testing, which is a quality control issue rather than a direct safety hazard like contamination or mislabeling.
Plain-English summary
Shionogi Inc. is recalling 455 bottles of PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles. The product is prescription-only and was manufactured by Halo Pharmaceutical Inc. for Shionogi Inc.
The recall was initiated because low dissolution results were obtained during stability testing. The affected product is identified by Lot # 5H66200103 with an expiration date of June 2018. The recall is classified as Class III by the FDA.
The product was distributed nationwide. Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If the product is found, it should be returned to the pharmacy or point of purchase for a refund or replacement.
The recalled product
- Product
- PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981
- Manufacturer
- Shionogi Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 455
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 5H66200103
- Exp. June 2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Shionogi Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Shionogi Inc.
See all →- LowShionogi Recalls Mefenamic Acid Capsules Due to Foreign Particles
FDA (Drugs) · 2018-01-24
- LowShionogi Recalls Mefenamic Acid Capsules for Dissolution Failures
FDA (Drugs) · 2017-07-26
- LowShionogi Recalls Nisoldipine Extended Release Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2015-08-12
- ModerateShionogi Recalls Nisoldipine Extended Release Tablets for Dissolution Failure
FDA (Drugs) · 2012-07-04
Same hazard · failed dissolution
See all →- ModerateNovartis Recalls Diovan Valsartan Tablets Due to Failed Dissolution Specifications
FDA (Drugs) · 2026-08-19
- LowSupernus Recalls Trokendi XR Capsules for Failed Dissolution Specifications
FDA (Drugs) · 2026-07-29
- HighAscend amlodipine and olmesartan tablets failed dissolution specifications
FDA (Drugs) · 2026-06-10
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10
- HighMajor Pharmaceuticals memantine extended-release capsules fail dissolution specifications
FDA (Drugs) · 2026-04-22